Canadian RWE Shows Comparable Outcomes Between Etanercept Biosimilars, Originator
August 26th 2025
By Skylar Jeremias
ArticleCanadian study reveals no significant differences in remission outcomes between etanercept biosimilars and the originator, Enbrel, for rheumatoid arthritis patients.